Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-050467
Filing Date
2025-11-07
Accepted
2025-11-07 10:26:59
Documents
1
Period of Report
2025-11-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1762529216.html 4  
1 FORM 4 wk-form4_1762529216.xml 4 3907
  Complete submission text file 0001628280-25-050467.txt   5696
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Issuer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address DAVITA INC. 2000 16TH STREET, ATTN JLD/SECGOVFIN DENVER CO 80202
Business Address
ACKERMAN JOEL (Reporting) CIK: 0001220630 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-11504 | Film No.: 251460954